Bristol-Myers Squibb Receives FDA Approval For ZENBEXUS In Combination With Daratumumab And Hyaluronidase-fihj and Dexamethasone For Patients with Multiple Myeloma

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.